Items where Author is "Bernasconi, E."

Article

Gebreselassie, H. M. and Kraus, D. and Fux, C. A. and Haubitz, S. and Scherrer, A. and Hatz, C. and Veit, O. and Stoeckle, M. and Fehr, J. and de Lucia, S. and Cavassini, M. and Bernasconi, E. and Schmid, P. and Furrer, H. and Staehelin, C. and Swiss HIV Cohort Study, . (2017) Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study. HIV Medicine, 18 (8). pp. 564-572.

Conen, A. and Wang, Q. and Glass, T. R. and Fux, C. A. and Thurnheer, M. C. and Orasch, C. and Calmy, A. and Bernasconi, E. and Vernazza, P. and Weber, R. and Bucher, H. C. and Battegay, M. and Fehr, J.. (2013) Association of Alcohol Consumption and HIV Surrogate Markers in Participants of the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 64 (5). pp. 472-478.

Nuesch, R. and Wang, Q. and Elzi, L. and Bernasconi, E. and Weber, R. and Cavassini, M. and Vernazza, P. and Thurnheer, M. C. and Calmy, A. and Battegay, M. and Bucher, H. C. and Swiss, H. I. V. Cohort Study. (2013) Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). Journal of Acquired Immune Deficiency Syndromes, 62 (4). pp. 396-404.

Beerenwinkel, N. and Montazeri, H. and Schuhmacher, H. and Knupfer, P. and von Wyl, V. and Furrer, H. and Battegay, M. and Hirschel, B. and Cavassini, M. and Vernazza, P. and Bernasconi, E. and Yerly, S. and Boni, J. and Klimkait, T. and Cellerai, C. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2013) The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients. PLoS Computational Biology, Vol. 9, H. 8 , e1003203.

Scherrer, A. U. and Boni, J. and Yerly, S. and Klimkait, T. and Aubert, V. and Furrer, H. and Calmy, A. and Cavassini, M. and Elzi, L. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Gunthard, H. F. and Swiss HIV Cohort Study Shcs, . (2012) Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens. PLoS one, Vol. 7, H. 11 , e50307.

Scherrer, A. U. and Ledergerber, B. and von Wyl, V. and Boni, J. and Yerly, S. and Klimkait, T. and Cellerai, C. and Furrer, H. and Calmy, A. and Cavassini, M. and Elzi, L. and Vernazza, P. L. and Bernasconi, E. and Gunthard, H. F. and Swiss HIV Cohort Study Shcs, . (2012) Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PLoS one, Vol. 7, H. 6 , e37983.

Thierfelder, C. and Weber, R. and Elzi, L. and Furrer, H. and Cavassini, M. and Calmy, A. and Bernasconi, E. and Gutmann, C. and Ledergerber, B. and Swiss HIV Cohort Study Group, . (2012) Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV medicine, Vol. 13. pp. 118-126.

Fenner, L. and Gagneux, S. and Janssens, J. P. and Fehr, J. and Cavassini, M. and Hoffmann, M. and Bernasconi, E. and Schrenzel, J. and Bodmer, T. and Bottger, E. C. and Helbling, P. and Egger, M.. (2012) Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country : clinical characteristics and treatment outcomes. PLoS one, Vol. 7, H. 3 , e34186.

Kouyos, R. D. and von Wyl, V. and Yerly, S. and Boni, J. and Rieder, P. and Joos, B. and Taffe, P. and Shah, C. and Burgisser, P. and Klimkait, T. and Weber, R. and Hirschel, B. and Cavassini, M. and Rauch, A. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Bonhoeffer, S. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2011) Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clinical Infectious Diseases, Vol. 52, H. 4. pp. 532-539.

El Amari, E. Boffi and Combescure, C. and Yerly, S. and Calmy, A. and Kaiser, L. and Hasse, B. and Furrer, H. and Cavassini, M. and Vernazza, P. and Hirsch, Hh and Bernasconi, E. and Hirschel, B. and Swiss HIV Cohort Study, . (2011) Clinical relevance of cytomegalovirus viraemia(*,†). HIV medicine, Vol. 12, H. 7. pp. 394-402.

Young, J. and Scherrer, A. U. and Günthard, H. F. and Opravil, M. and Yerly, S. and Böni, J. and Rickenbach, M. and Fux, C. A. and Cavassini, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B. and Battegay, M. and Bucher, H. C. and Swiss HIV Cohort Study, . (2011) Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients : the Swiss HIV Cohort Study. HIV medicine, Vol. 12, H. 5. pp. 299-307.

Magenta, L. and Dell-Kuster, S. and Richter, W. O. and Young, J. and Hasse, B. and Flepp, M. and Hirschel, B. and Vernazza, P. and Evison, J. and Cavassini, M. and Decosterd, L. A. and Bucher, H. C. and Bernasconi, E. and Swiss HIV Cohort Study, . (2011) Lipid and lipoprotein profile in HIV-infected patients treated with lopinavir/ritonavir as a component of the first combination antiretroviral therapy. AIDS research and human retroviruses, Vol. 27, H. 5. pp. 525-533.

Fehr, J. and Glass, T. R. and Louvel, S. and Hamy, F. and Hirsch, H. H. and von Wyl, V. and Boni, J. and Yerly, S. and Burgisser, P. and Cavassini, M. and Fux, C. A. and Hirschel, B. and Vernazza, P. and Martinetti, G. and Bernasconi, E. and Gunthard, H. F. and Battegay, M. and Bucher, H. C. and Klimkait, T.. (2011) Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study. Journal of translational medicine, Vol. 9 , 14. p. 14.

Ledergerber, B. and Cavassini, M. and Battegay, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B. and Furrer, H. and Rickenbach, M. and Weber, R. and Swiss HIV Cohort Study, . (2011) Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study. HIV medicine, Vol. 12, H. 5. pp. 279-288.

Scherrer, A. U. and von Wyl, V. and Boni, J. and Yerly, S. and Klimkait, T. and Burgisser, P. and Garzoni, C. and Hirschel, B. and Cavassini, M. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Gunthard, H. F. and Swiss HIV Cohort Study Shcs, . (2011) Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. JAIDS, Vol. 57, H. 1. pp. 24-31.

Kouyos, R. D. and von Wyl, V. and Yerly, S. and Boni, J. and Rieder, P. and Joos, B. and Taffe, P. and Shah, C. and Burgisser, P. and Klimkait, T. and Weber, R. and Hirschel, B. and Cavassini, M. and Rauch, A. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Bonhoeffer, S. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2010) Ambiguity in population-based sequencing of HIV-1 as a marker for the age of HIV infection. Antiviral therapy, Vol. 15 , A158-A158.

Combescure, Christophe and Vallier, N. and Ledergerber, B. and Cavassini, M. and Furrer, H. and Rauch, A. and Battegay, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B.. (2009) How reliable is an undetectable viral load? HIV medicine : the official journal of the British HIV Association (BHIVA) and the European AIDS Clinical Society (EACS), Vol. 10. pp. 470-476.

Bellini, C. and Keiser, O. and Chave, J. P. and Evison, J. and Fehr, J. and Kaiser, L. and Weber, R. and Vernazza, P. and Bernasconi, E. and Telenti, A. and Cavassini, M. and Swiss, HIV Cohort Study. (2009) Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients : the Swiss HIV cohort study. HIV medicine : the official journal of the British HIV Association (BHIVA) and the European AIDS Clinical Society (EACS), Vol. 10. pp. 12-18.

Wunder, D. M. and Fux, C. A. and Bersinger, N. A. and Mueller, N. J. and Hirschel, B. and Cavassini, M. and Elzi, L. and Schmid, P. and Bernasconi, E. and Mueller, B. and Furrer, H. and Swiss, HIV Cohort Study. (2008) Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy : a case-control study. HIV medicine, Vol. 9. pp. 427-432.

Khanna, N. and Opravil, M. and Furrer, H. and Cavassini, M. and Vernazza, P. and Bernasconi, E. and Weber, R. and Hirschel, B. and Battegay, M. and Kaufmann, G. R. and Swiss, HIV Cohort Study. (2008) CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clinical Infectious Diseases, Vol. 47. pp. 1093-1101.

Wolbers, M. and Bucher, H. C. and Furrer, H. and Rickenbach, M. and Cavassini, M. and Weber, R. and Schmid, P. and Bernasconi, E. and Hirschel, B. and Battegay, M. and Swiss, HIV Cohort Study. (2008) Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV medicine, Vol. 9. pp. 397-405.

Vo, T. T. and Ledergerber, B. and Keiser, O. and Hirschel, B. and Furrer, H. and Battegay, M. and Cavassini, M. and Bernasconi, E. and Vernazza, P. and Weber, R. and Swiss, HIV Cohort Study. (2008) Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. Journal of Infectious Diseases, Vol. 197, no. 12. pp. 1685-1694.

von Wyl, V. and Yerly, S. and Böni, J. and Bürgisser, P. and Klimkait, T. and Battegay, M. and Bernasconi, E. and Cavassini, M. and Furrer, H. and Hirschel, B. and Vernazza, P. L. and Rickenbach, M. and Ledergerber, B. and Günthard, H. F. and Swiss, HIV Cohort Study. (2008) Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical Infectious Diseases, Vol. 46. pp. 1299-1309.

Nguyen, A. and Calmy, A. and Schiffer, V. and Bernasconi, E. and Battegay, M. and Opravil, M. and Evison, J. M. and Tarr, P. E. and Schmid, P. and Perneger, T. and Hirschel, B. and Swiss, HIV Cohort Study. (2008) Lipodystrophy and weight changes : data from the Swiss HIV Cohort Study, 2000-2006. HIV medicine, Vol. 9. pp. 142-150.

Ciuffreda, D. and Comte, D. and Cavassini, M. and Giostra, E. and Bühler, L. and Perruchoud, M. and Heim, M. H. and Battegay, M. and Genné, D. and Mulhaupt, B. and Malinverni, R. and Oneta, C. and Bernasconi, E. and Monnat, M. and Cerny, A. and Chuard, C. and Borovicka, J. and Mentha, G. and Pascual, M. and Gonvers, J. J. and Pantaleo, G. and Dutoit, V.. (2008) Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. European Journal of Immunology, Vol. 38, H. 10. pp. 2665-2677.

El Amari, E. B. and Toutous-Trellu, L. and Gayet-Ageron, A. and Baumann, M. and Cathomas, G. and Steffen, I. and Erb, P. and Mueller, N. J. and Furrer, H. and Cavassini, M. and Vernazza, P. and Hirsch, H. H. and Bernasconi, E. and Hirschel, B. and Swiss, HIV Cohort Study. (2008) Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. AIDS, Vol. 22. pp. 1019-1028.

Glass, T. R. and De Geest, S. and Hirschel, B. and Battegay, M. and Furrer, H. and Covassini, M. and Vernazza, P. L. and Bernasconi, E. and Rickenboch, M. and Weber, R. and Bucher, H. C. and Swiss, HIV Cohort Study. (2008) Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antiviral therapy, Vol. 13. pp. 77-85.

Zellweger, C. and Opravil, M. and Bernasconi, E. and Cavassini, M. and Bucher, H. C. and Schiffer, V. and Wagels, T. and Flepp, M. and Rickenbach, M. and Furrer, H. and Swiss, H. I. V. Cohort Study. (2004) Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: prospective multicentre study. AIDS, 18 (15). pp. 2047-2053.